Post-approval studies (Phase 4)WithdrawnNCT06169826
What this trial is testing
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
Who this might be right for
Alzheimer Disease
Wake Forest University Health Sciences
Showing 20 of 0 results